Another 13 % are selling capital equipment, and 12 % are selling biotech products. (medreps.com)
We're becoming increasingly acknowledged as a strong biotechnology player; roughly one third of our revenues are associated with biotech products. (sciencemag.org)
One challenge regulators will face is finding jurisdiction under existing statutes to regulate the diverse range of anticipated biotech products, the report says. (sciencedaily.com)